Noetic Fund invests in early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Noetic Fund is a venture fund launched by Grey House Partners GP Inc. to invest in emerging and early-stage wellness, therapeutic and pharmaceutical companies around the globe. The company has proudly taken the North Star pledge and believes in the importance of stewarding this sector in the right way. It aims to nurture the scientific advancement of mental, emotional, psychological and physical health by investing in alternative therapies, modalities, and sciences that are committed to optimizing our human experience.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2021 | Delix Therapeutics | Series A | 0 |
9/2021 | CaaMTech | Series A | 22M |
5/2021 | Apollo Neuroscience | Series A | 0 |
2/2021 | Bexson Biomedical | Series A | 4.8M |
5/2021 | Woven Science | Seed Round | 8.5M |
9/2022 | Damona Pharmaceuticals | Seed Round | 0 |
12/2020 | Beckley Psytech | Venture Round | 0 |
3/2022 | Apollo Neuroscience | Series A | 0 |
1/2021 | People Science | Seed Round | 3.2M |
7/2020 | Cybin | Series B | 0 |
5/2021 | Gilgamesh Pharmaceuticals | Series A | 0 |
9/2021 | Sana Health | Convertible Note | 0 |
3/2022 | Apollo Neuroscience | Series A | 0 |
9/2021 | Delix Therapeutics | Series A | 0 |
9/2021 | CaaMTech | Series A | 0 |
9/2021 | Sana Health | Convertible Note | 0 |
5/2021 | Apollo Neuroscience | Series A | 0 |
5/2021 | Woven Science | Seed Round | 0 |
5/2021 | Gilgamesh Pharmaceuticals | Series A | 0 |
2/2021 | Bexson Biomedical | Series A | 0 |
12/2020 | Beckley Psytech | Venture Round | 0 |
7/2020 | Cybin | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|